MedWatch

ALK given new date for crucial FDA meeting

US medicines agency, FDA, has set a new date for the postponed meeting to discuss the future for an oral vaccine from ALK and the Danish company’s US partner Merck.

Foto: ALK-Abelló / PR

First it was postponed due to the halted budget talks and following government shutdown in the US, but ALK are now finally able to mark its calendar.

The FDA has set a new date for the meeting of its advisory panel for December 12, 2013, at which time the registration application for the company’s vaccine to treat grass pollen allergy will be reviewed, ALK writes in a stock market release Wednesday morning.

Allerede abonnent? Log ind.

Læs hele artiklen

Få adgang i 14 dage for 0 kr.
Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.

  • Adgang til alle låste artikler
  • Modtag vores daglige nyhedsbreve
  • Fuld adgang til vores app
Der skete en fejl. Prøv venligst igen senere

Få fuld adgang til dig og dine kollegaer.

Start et gratis virksomhedsprøveabonnement

Mere fra MedWatch

Relaterede

Seneste nyt

MedWatch job

Se flere jobs

Se flere jobs

Watch job

Se flere jobs

Se flere jobs

Latest news

Seneste nyt fra Watch Medier